Esters and amides of hexanoic acid substituted with tertiary amino group in terminal position and their activity as transdermal permeation enhancers

Series of alkyl esters of 6-(diethylamino)-, 6-(pyrrolidin-1-yl)-, 6-(pi¬peridin-1-yl) and 6-(morpholin-4-yl)hexanoic acids and alkylamides of 6-(dimethylamino)-, 6-(piperidin-1-yl) and 6-(morpholin-4-yl)hexanoic acids, containing 8–12 carbon atoms in the alkyl chain, were prepared by methods of classical organic synthesis. The appropriate secondary amine was alkylated with ethyl 6-bromohexanoate to give ester of ω-substituted hexanoic acid, except of ethyl 6-(dimethylamino)hexanoate (1), which was prepared by Eschweiler–Clarke methylation of 6-aminohexanoic acid followed by direct esterification with ethanol. The resulted esters of ω-substituted hexanoic acids underwent direct transesterification with long chain alkanols to yield the desired amino esters, or they were treated with long-chain alkylamines to prepare secondary amides of the appropriate heterocyclic hexanoic acids. These products were in vitro tested on their activity as transdermal permeation enhancers on the strips of the excised human skin with theophylline as the model permeant. The activity was evaluated using parameter enhancement ratio (ER), defined as the ratio between the overall amount of the permeant passing through the skin with the tested enhancer and that without tested substance. Decyl 6-(pyrrolidin-1-yl)hexanoate (9) with ER = 30 showed the highest activity. The enhancing effects of the esters were generally better than those of the amides

Esters and amides of hexanoic acid substituted with tertiary amino group in terminal position and their activity as transdermal permeation enhancers - Supplementary material

n/